Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma

Hyung Soon Park, Yu Jin Kim, Woo Ick Yang, Chang-Ok Suh, Yongchan Lee

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

AIM: To investigate treatment outcome of Helicobacter pylori (H. pylori)-negative low-grade gastric mucosa-associated lymphoid tissue (MALT) lymphoma. METHODS: In this study, we retrospectively reviewed the clinical outcome and clinicopathologic factors of stage IE H. pylori-negative low-grade gastric MALT lymphoma cases from August 1998 to June 2009. RESULTS: A total of eleven patients with H. pylori-negative low-grade gastric MALT lymphoma were enrolled in the study and received anti-H. pylori eradication treatment and/or radiotherapy or excisional therapy. Complete remission (CR) of gastric MALT lymphoma was achieved in all patients. The time to CR was 1-66 mo (median, 1 mo). CONCLUSION: Eradication therapy may be offered as an initial treatment option even in cases of localized H. pylori-negative gastric MALT lymphoma.

Original languageEnglish
Pages (from-to)2158-2162
Number of pages5
JournalWorld Journal of Gastroenterology
Volume16
Issue number17
DOIs
Publication statusPublished - 2010 May 24

Fingerprint

Marginal Zone B-Cell Lymphoma
Gastric Mucosa
Helicobacter pylori
Therapeutics
Radiotherapy

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

@article{a2d65c35e8454fa3ba660e9deeb3a410,
title = "Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma",
abstract = "AIM: To investigate treatment outcome of Helicobacter pylori (H. pylori)-negative low-grade gastric mucosa-associated lymphoid tissue (MALT) lymphoma. METHODS: In this study, we retrospectively reviewed the clinical outcome and clinicopathologic factors of stage IE H. pylori-negative low-grade gastric MALT lymphoma cases from August 1998 to June 2009. RESULTS: A total of eleven patients with H. pylori-negative low-grade gastric MALT lymphoma were enrolled in the study and received anti-H. pylori eradication treatment and/or radiotherapy or excisional therapy. Complete remission (CR) of gastric MALT lymphoma was achieved in all patients. The time to CR was 1-66 mo (median, 1 mo). CONCLUSION: Eradication therapy may be offered as an initial treatment option even in cases of localized H. pylori-negative gastric MALT lymphoma.",
author = "Park, {Hyung Soon} and Kim, {Yu Jin} and Yang, {Woo Ick} and Chang-Ok Suh and Yongchan Lee",
year = "2010",
month = "5",
day = "24",
doi = "10.3748/wjg.v16.i17.2158",
language = "English",
volume = "16",
pages = "2158--2162",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "17",

}

Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma. / Park, Hyung Soon; Kim, Yu Jin; Yang, Woo Ick; Suh, Chang-Ok; Lee, Yongchan.

In: World Journal of Gastroenterology, Vol. 16, No. 17, 24.05.2010, p. 2158-2162.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma

AU - Park, Hyung Soon

AU - Kim, Yu Jin

AU - Yang, Woo Ick

AU - Suh, Chang-Ok

AU - Lee, Yongchan

PY - 2010/5/24

Y1 - 2010/5/24

N2 - AIM: To investigate treatment outcome of Helicobacter pylori (H. pylori)-negative low-grade gastric mucosa-associated lymphoid tissue (MALT) lymphoma. METHODS: In this study, we retrospectively reviewed the clinical outcome and clinicopathologic factors of stage IE H. pylori-negative low-grade gastric MALT lymphoma cases from August 1998 to June 2009. RESULTS: A total of eleven patients with H. pylori-negative low-grade gastric MALT lymphoma were enrolled in the study and received anti-H. pylori eradication treatment and/or radiotherapy or excisional therapy. Complete remission (CR) of gastric MALT lymphoma was achieved in all patients. The time to CR was 1-66 mo (median, 1 mo). CONCLUSION: Eradication therapy may be offered as an initial treatment option even in cases of localized H. pylori-negative gastric MALT lymphoma.

AB - AIM: To investigate treatment outcome of Helicobacter pylori (H. pylori)-negative low-grade gastric mucosa-associated lymphoid tissue (MALT) lymphoma. METHODS: In this study, we retrospectively reviewed the clinical outcome and clinicopathologic factors of stage IE H. pylori-negative low-grade gastric MALT lymphoma cases from August 1998 to June 2009. RESULTS: A total of eleven patients with H. pylori-negative low-grade gastric MALT lymphoma were enrolled in the study and received anti-H. pylori eradication treatment and/or radiotherapy or excisional therapy. Complete remission (CR) of gastric MALT lymphoma was achieved in all patients. The time to CR was 1-66 mo (median, 1 mo). CONCLUSION: Eradication therapy may be offered as an initial treatment option even in cases of localized H. pylori-negative gastric MALT lymphoma.

UR - http://www.scopus.com/inward/record.url?scp=77952500811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952500811&partnerID=8YFLogxK

U2 - 10.3748/wjg.v16.i17.2158

DO - 10.3748/wjg.v16.i17.2158

M3 - Article

VL - 16

SP - 2158

EP - 2162

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 17

ER -